Publications by authors named "Anna Lach"

Claim this Profile
R
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.
Michael A Chapman, Jonathan Sive, John Ambrose, Claire Roddie, Nicholas Counsell, Anna Lach

Blood· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models.
Alex Dyson, Felipe Dal-Pizzol, Giovanni Sabbatini, Anna B Lach, Federica Galfo

PLoS Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloma impairs mature osteoblast function but causes early expansion of osteo-progenitors: temporal changes in bone physiology and gene expression in the KMS12BM model.
Deepika Kassen, Darren Lath, Anna Lach, Holly Evans, Andy Chantry

Br J Haematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort analysis of FISH testing of CD138(+) cells in relapsed multiple myeloma: implications for prognosis and choice of therapy.
Dean Smith, Clemency Stephenson, Laura Percy, Anna Lach, Steve Chatters

Br J Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS mutation status and bortezomib therapy for relapsed multiple myeloma.
Dean Smith, Elena Armenteros, Laura Percy, Madhu Kumar, Anna Lach

Br J Haematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis